Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARSH & MCLENNAN COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARSH & MCLENNAN COMPANIES's regulatory disclosures and financial reporting.
Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.
Marsh & McLennan Companies director Jan Siegmund received an annual stock award of 1,349.82 restricted stock units on Marsh & McLennan common stock. The units were valued at $159.28 per underlying share and convert into common stock on a 1-for-1 basis.
Following this grant, Siegmund directly holds 2,298.24 restricted stock units linked to Marsh & McLennan common stock. This is a compensation-related award rather than an open-market purchase or sale.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills reported an annual stock award, not an open‑market trade. He received a grant of 1,349 shares of common stock at $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this compensation grant, he holds 5,757.75 shares directly and 47,553 shares indirectly through a trust.
HANWAY H EDWARD reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director H. Edward Hanway received an annual stock award of 1,349 shares of Common Stock. The award was granted on June 1, 2026 under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
After this grant, Hanway directly holds a total of 36,867.7 shares of Marsh & McLennan common stock. This is a compensation-related equity award, not an open‑market purchase or sale.
Hartmann Judith reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Judith Hartmann received an annual stock award of 1,349 shares of Common Stock. The shares were granted on June 1, 2026 at a reported price of $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan.
Following this grant, Hartmann directly holds 4,323 shares of the company’s common stock. This is a compensation-related award rather than an open-market purchase, so it reflects standard director remuneration rather than a trading decision based on the share price.
Marsh & McLennan Companies director Peter Harrison reported compensation-related stock transactions. He received an annual stock award of 1,349 shares of common stock under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
To cover applicable taxes on shares acquired with director fees under the same plan, 103.39 shares of common stock were withheld in a tax-withholding disposition. After these transactions and receipt of cash in lieu of a fractional share, Harrison directly holds 1,349.82 shares of Marsh & McLennan common stock.
BROUSSARD BRUCE D reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Bruce D. Broussard received an annual stock award of 1,349 shares of common stock on June 1, 2026 under the company’s Directors Stock Compensation Plan. The grant was valued at $159.28 per share and increased his direct holdings to 1,425 shares.
John Q. Doyle submitted a Form 144 notifying a proposed sale of 16,656 shares of Common Stock to be sold on 06/02/2026. The filing lists an option granted 02/22/2017 as the acquisition event and names Fidelity Brokerage Services LLC as the broker. A prior sale entry on 03/04/2026 shows $3,052,861.50 associated with 16,655 (listed nearby in the excerpt).
Marsh & McLennan Companies, Inc. held its Annual Meeting of Stockholders on May 21, 2026, with 436,451,305 shares represented, or 90.34% of the 483,095,948 shares of common stock entitled to vote. Stockholders elected thirteen directors to one-year terms expiring at the 2027 annual meeting or until their successors are elected and qualified.
Stockholders also approved, on a nonbinding basis, the compensation of the company’s named executive officers, with 362,069,913 shares voted for, 47,108,150 against and 2,053,496 abstentions, and ratified the selection of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Marsh & McLennan Companies director Morton O. Schapiro reported routine equity compensation activity. On May 15, 2026, he received 256.85 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, valued at $160.60 per unit. A separate adjustment of 495.08 restricted stock units reflects dividend equivalents credited under the same plan. Each restricted stock unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis, and Schapiro now holds more than 88,000 restricted stock units directly.